NASDAQ : EPRX
Eupraxia Pharmaceuticals Inc. — Financial statements
Healthcare · Biotechnology · Canada
Last price 6.83 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 449.68M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 20.84M | 17.10M | 10.92M | 7.48M | 3.99M | 6.48M |
| Research & Development | 36.26M | 21.33M | 16.08M | 20.36M | 13.63M | 7.58M |
| Operating Expenses | 57.11M | 38.43M | 27.00M | 27.85M | 17.62M | 14.15M |
| Operating Income | -57.11M | -38.43M | -27.00M | -27.85M | -17.62M | -14.15M |
| Interest Expense | -959.15K | -1.17M | -982.86K | -972.44K | ||
| Interest & Investment Income | 3.31M | 1.41M | 1.16M | 862.97K | 431.80K | 51.94K |
| Currency Exchange Gain (Loss) | 3.61M | -1.56M | -159.21K | 66.29K | 240.55K | 157.30K |
| Other Non Operating Income (Expenses) | 1.20M | -836.60K | -1.06M | -4.74M | ||
| EBT Excluding Unusual Items | -50.18M | -38.58M | -25.76M | -28.92M | -18.98M | -19.65M |
| Gain (Loss) on Sale of Assets | -4.19K | -2.56K | 18.61K | -4.85K | -6.64K | |
| Other Unusual Items | 422.34K | |||||
| Pretax Income | -50.18M | -38.59M | -25.74M | -28.93M | -18.99M | -19.23M |
| Income Tax Expense | 55.00K | 19.09K | 1.80K | 36.42K | ||
| Earnings From Continuing Operations | -50.24M | -38.61M | -25.74M | -28.97M | -18.99M | -19.23M |
| Minority Interest in Earnings | 25.97K | 29.51K | 241.95K | 745.21K | 501.13K | 300.24K |
| Net Income | -50.21M | -38.58M | -25.50M | -28.22M | -18.49M | -18.93M |
| Preferred Dividends & Other Adjustments | 2.46M | 2.53M | 425.56K | |||
| Net Income to Common | -52.68M | -41.11M | -25.93M | -28.22M | -18.49M | -18.93M |
| Shares Outstanding (Basic) | 52.80M | 39.96M | 33.93M | 24.15M | 19.29M | 12.41M |
| Shares Outstanding (Diluted) | 52.80M | 39.96M | 33.93M | 24.15M | 19.29M | 12.41M |
| EPS (Basic) | -1.00 | -1.03 | -0.76 | -1.17 | -0.96 | -1.53 |
| EPS (Diluted) | -1.00 | -1.03 | -0.76 | -1.17 | -0.96 | -1.53 |
| Free Cash Flow | -38.23M | -29.14M | -30.10M | -20.82M | -14.63M | -12.06M |
| Free Cash Flow Per Share | -0.72 | -0.73 | -0.89 | -0.86 | -0.76 | -0.97 |
| EBITDA | -56.87M | -38.27M | -26.89M | -27.73M | -17.51M | -14.11M |
| D&A For EBITDA | 239.36K | 164.40K | 114.03K | 112.88K | 110.10K | 43.66K |
| EBIT | -57.11M | -38.43M | -27.00M | -27.85M | -17.62M | -14.15M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 52.43M | 80.56M | 33.10M | 19.34M | 18.26M | 16.51M |
| Short-Term Investments | 81.23M | 7.12M | ||||
| Cash & Short-Term Investments | 133.66M | 80.56M | 33.10M | 19.34M | 18.26M | 23.63M |
| Other Receivables | 688.22K | 674.23K | 228.87K | 190.61K | 89.72K | 339.57K |
| Receivables | 688.22K | 674.23K | 228.87K | 190.61K | 89.72K | 339.57K |
| Prepaid Expenses | 2.46M | 3.86M | 1.11M | 270.71K | 235.90K | 214.13K |
| Total Current Assets | 136.80M | 85.10M | 34.44M | 19.80M | 18.59M | 24.18M |
| Property, Plant & Equipment | 3.05M | 987.13K | 424.92K | 456.25K | 530.75K | 465.49K |
| Other Long-Term Assets | 53.70K | 64.33K | 80.76K | 6.90K | 2.49K | 24.79K |
| Total Assets | 139.91M | 86.15M | 34.94M | 20.27M | 19.12M | 24.67M |
| Accrued Expenses | 7.33M | 5.51M | 3.01M | 3.87M | 2.91M | 1.67M |
| Current Portion of Long-Term Debt | 10.40M | 79.42K | 75.00K | |||
| Current Portion of Leases | 159.88K | 78.45K | 71.86K | 53.32K | 50.40K | 47.32K |
| Current Income Taxes Payable | 21.18K | 1.61K | 36.42K | |||
| Other Current Liabilities | 1.04M | 40.17K | 20.70K | 5.02M | 16.00K | 3.96K |
| Total Current Liabilities | 8.55M | 5.63M | 3.10M | 19.37M | 3.06M | 1.79M |
| Long-Term Debt | 8.80M | 7.66M | ||||
| Long-Term Leases | 1.68M | 75.91K | 51.30K | 108.85K | ||
| Total Liabilities | 10.23M | 5.70M | 3.10M | 19.37M | 11.91M | 9.56M |
| Common Stock | 264.18M | 195.41M | 116.36M | 92.91M | 71.00M | 61.36M |
| Additional Paid-In Capital | 41.31M | 28.52M | 20.50M | 17.51M | 16.85M | |
| Retained Earnings | -196.72M | -169.58M | -131.00M | -105.50M | -77.28M | -58.68M |
| Comprehensive Income & Other | -7.01M | -2.04M | -4.16M | -2.71M | -2.79M | 13.09M |
| Total Common Equity | 101.75M | 52.30M | 1.70M | 2.22M | 7.79M | 15.77M |
| Minority Interest | -1.60M | -1.60M | -1.57M | -1.32M | -578.67K | -658.90K |
| Shareholders' Equity | 129.67M | 80.45M | 31.84M | 892.33K | 7.21M | 15.11M |
| Total Liabilities & Equity | 139.91M | 86.15M | 34.94M | 20.27M | 19.12M | 24.67M |
| Total Debt | 1.84M | 154.36K | 71.86K | 10.45M | 8.99M | 7.90M |
| Net Cash (Debt) | 131.82M | 80.41M | 33.03M | 8.89M | 9.28M | 15.73M |
| Net Cash Per Share | 2.50 | 2.01 | 0.97 | 0.37 | 0.48 | 1.27 |
| Filing Date Shares Outstanding | 65.91M | 61.50M | 35.85M | 35.62M | 27.36M | 14.24M |
| Total Common Shares Outstanding | 65.47M | 51.94M | 35.64M | 27.28M | 21.59M | 14.24M |
| Working Capital | 128.25M | 79.47M | 31.33M | 429.18K | 15.53M | 22.39M |
| Book Value Per Share | 1.55 | 1.01 | 0.05 | 0.08 | 0.36 | 1.11 |
| Tangible Book Value | 101.75M | 52.30M | 1.70M | 2.22M | 7.79M | 15.77M |
| Tangible Book Value Per Share | 1.55 | 1.01 | 0.05 | 0.08 | 0.36 | 1.11 |
| Buildings | 73.40K | |||||
| Machinery | 1.83M | 1.35M | 699.22K | 678.88K | 610.53K | 101.94K |
| Leasehold Improvements | 137.59K | 127.83K | 118.36K | 128.77K | 125.74K | 134.58K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -50.21M | -38.58M | -25.50M | -28.22M | -18.49M | -18.93M |
| Depreciation & Amortization | 360.88K | 237.72K | 171.72K | 155.53K | 147.89K | 88.13K |
| Loss (Gain) From Sale of Assets | 4.19K | 2.56K | -18.61K | 4.85K | 6.88K | |
| Stock-Based Compensation | 11.43M | 8.76M | 3.22M | 1.41M | 1.43M | 2.71M |
| Other Operating Activities | -4.71M | 1.74M | -1.10M | 547.78K | 991.27K | 4.72M |
| Change in Accounts Receivable | -537.75K | -431.45K | -101.39K | -103.71K | 230.48K | 150.84K |
| Change in Accounts Payable | 5.81M | 2.36M | -714.88K | 577.91K | 1.32M | -500.48K |
| Change in Other Net Operating Assets | 379.39K | -2.64M | -5.95M | 4.88M | -39.96K | 51.49K |
| Operating Cash Flow | -37.47M | -28.55M | -29.99M | -20.75M | -14.40M | -11.72M |
| Capital Expenditures | -753.72K | -588.95K | -104.23K | -73.38K | -235.55K | -341.11K |
| Sale of Property, Plant & Equipment | 29.07K | 242.00 | ||||
| Investment in Securities | -79.72M | 10.07M | -7.11M | |||
| Other Investing Activities | -3.97M | |||||
| Investing Cash Flow | -80.48M | -588.95K | -75.16K | -73.38K | 9.83M | -11.42M |
| Short-Term Debt Issued | 79.02K | |||||
| Long-Term Debt Issued | 10.08M | |||||
| Total Debt Issued | 10.16M | |||||
| Long-Term Debt Repaid | -9.14M | -79.44K | -142.27K | -463.40K | ||
| Lease Payments | -67.42K | -69.30K | ||||
| Net Debt Issued (Repaid) | -9.14M | -79.44K | -142.27K | 9.69M | ||
| Issuance of Common Stock | 142.18M | 76.06M | 54.92M | 21.16M | 10.94M | 29.90M |
| Other Financing Activities | 9.27M | |||||
| Financing Cash Flow | 151.45M | 76.06M | 45.78M | 21.08M | 10.80M | 39.59M |
| Foreign Exchange Rate Adjustments | -835.59K | 544.81K | -1.96M | 821.40K | -507.39K | -64.50K |
| Net Cash Flow | 32.66M | 47.46M | 13.76M | 1.08M | 5.73M | 16.39M |
| Free Cash Flow | -38.23M | -29.14M | -30.10M | -20.82M | -14.63M | -12.06M |
| Free Cash Flow Per Share | -0.72 | -0.73 | -0.89 | -0.86 | -0.76 | -0.97 |
| Levered Free Cash Flow | -18.93M | -16.30M | -20.95M | -10.78M | -8.72M | -12.98M |
| Unlevered Free Cash Flow | -18.93M | -16.30M | -20.35M | -10.05M | -8.11M | -12.37M |
| Free Cash Flow After Leases | -38.23M | -29.14M | -30.10M | -20.82M | -14.70M | -12.13M |
| Cash Interest Paid | 393.64K | 598.05K | 326.63K | 457.12K | ||
| Change in Working Capital | 5.65M | -713.70K | -6.76M | 5.35M | 1.51M | -298.15K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 449.68M | 381.21M | 111.66M | 110.94M | 58.23M | 27.57M |
| Enterprise Value | 343.94M | 321.61M | 102.16M | 95.96M | 42.78M | 7.77M |
| Last Close Price | 6.83 | 7.55 | 3.17 | 4.16 | 2.69 | 2.30 |
| PB Ratio | 3.47 | 4.74 | 3.51 | 124.32 | 8.08 | 1.82 |
| P/TBV Ratio | 4.42 | 7.29 | 65.70 | 50.06 | 7.48 | 1.75 |
| Debt / Equity Ratio | 0.01 | 0.00 | 0.00 | 11.71 | 1.25 | 0.52 |
| Net Debt / Equity Ratio | -1.02 | -1.00 | -1.04 | -9.96 | -1.29 | -1.04 |
| Net Debt / EBITDA Ratio | 2.32 | 2.10 | 1.23 | 0.32 | 0.53 | 1.11 |
| Net Debt / FCF Ratio | 3.45 | 2.76 | 1.10 | 0.43 | 0.63 | 1.30 |
| Quick Ratio | 15.71 | 14.44 | 10.74 | 1.01 | 6.00 | 13.38 |
| Current Ratio | 16.00 | 15.12 | 11.10 | 1.02 | 6.08 | 13.49 |
| Return on Equity (ROE) | -66.70% | -68.76% | -157.31% | -715.19% | -178.04% | |
| Return on Assets (ROA) | -43.66% | -39.67% | -61.14% | -88.37% | -52.20% | -68.51% |
| Return on Capital Employed (ROCE) | -43.50% | -47.70% | -84.80% | -3,120.70% | -109.70% | -61.90% |
| Earnings Yield | -14.84% | -10.12% | -22.84% | -25.44% | -31.75% | -68.66% |
| FCF Yield | -8.50% | -7.64% | -26.96% | -18.77% | -25.12% | -43.73% |
| Buyback Yield / Dilution | -47.80% | -17.76% | -40.52% | -25.21% | -55.45% | -102.75% |